PRIA Healthcare News and Insights
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's Second Quarter in Review
Continuing and Strengthening our Relationship with a Vital Industry Event
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide
US Reimbursement Policy in Flux
Prior Authorization is Coming to Fee-for-Service Medicare -- What You Need to Know About CMS's Proposed WISeR Model -- a webinar from PRIA Healthcare
